Related Experiment Video
Updated: Oct 3, 2025
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
The Role of Graphene Oxide Nanocarriers in Treating Gliomas
Bin Wang1, Hanfei Guo2, Haiyang Xu1
1Department of Neurosurgery, The First Hospital of Jilin University, Changchun, China.
Abstract:
Gliomas are the most common primary malignant tumors of the central nervous system, and their conventional treatment involves maximal safe surgical resection combined with radiotherapy and temozolomide chemotherapy; however, this treatment does not meet the requirements of patients in terms of survival and quality of life. Graphene oxide (GO) has excellent physical and chemical properties and plays an important role in the treatment of gliomas mainly through four applications, viz. direct killing, drug delivery, immunotherapy, and phototherapy. This article reviews research on GO nanocarriers in the treatment of gliomas in recent years and also highlights new ideas for the treatment of these tumors.
Insights
Graphene oxide (GO) shows promise in treating brain gliomas by directly killing tumors, delivering drugs, and enhancing immunotherapy and phototherapy, offering new hope beyond conventional treatments.
Area of Science:
- Neuro-oncology
- Nanomedicine
- Materials Science
Background:
- Gliomas are primary malignant brain tumors with limited treatment efficacy.
- Current treatments (surgery, radiotherapy, chemotherapy) fail to meet patient survival and quality of life needs.
Purpose of the Study:
- To review recent advancements in using graphene oxide (GO) nanocarriers for glioma treatment.
- To highlight novel therapeutic strategies involving GO for gliomas.
Main Methods:
- Review of scientific literature on graphene oxide applications in glioma therapy.
- Analysis of GO's mechanisms: direct cytotoxicity, drug delivery, immunotherapy, and phototherapy.
Main Results:
- Graphene oxide demonstrates multifaceted therapeutic potential in preclinical glioma models.
- GO facilitates targeted drug delivery and enhances anti-tumor immune responses.
- GO-based phototherapy offers a non-invasive treatment modality for gliomas.
Conclusions:
- Graphene oxide nanocarriers represent a promising platform for innovative glioma treatment strategies.
- Further research into GO applications could significantly improve outcomes for glioma patients.
More Related Videos
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010